Lívia Leite Góes Gitaí

Lívia Leite Góes Gitaí

Auto-generated profile, based on publicly available information

Lívia Leite Góes Gitaí

Universidade Federal de Alagoas, Faculdade de Medicina, Maceió AL, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2023 in Arquivos de Neuro-Psiquiatria
Verified
Journal Article
Open access
PDF file
MSMANOEL SOBREIRA
MANOEL SOBREIRA
FSFernando Gustavo Stelzer
Fernando Gustavo Stelzer
LGLívia Leite Góes Gitaí
Lívia Leite Góes Gitaí
RARosana Cardoso Alves
Rosana Cardoso Alves
AEAlan Luiz Eckeli
Alan Luiz Eckeli
CSCarlos H. Schenck
Carlos H. Schenck
REM sleep behavior disorder (RBD) is characterized by a loss of atonia of skeletal muscles during REM sleep, associated with acting out behaviors during dreams. Knowledge of this pathology is important to predict neurodegenerative diseases since there is a strong association of RBD with diseases caused by the deposition of alpha-synuclein in neurons (synucleinopathies), such as Parkinson's disease (PD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB). Proper diagnosis of this condition will enable the use of future neuroprotective strategies before motor and cognitive symptoms. Diagnostic assessment should begin with a detailed clinical history with the patient and bed partner or roommate and the examination of any recorded home videos. Polysomnography (PSG) is necessary to verify the loss of sleep atonia and, when documented, the behaviors during sleep. Technical recommendations for PSG acquisition and analysis are defined in the AASM Manual for the scoring of sleep and associated events, and the PSG report should describe the percentage of REM sleep epochs that meet the criteria for RWA (REM without atonia) to better distinguish patients with and without RBD. Additionally, PSG helps rule out conditions that may mimic RBD, such as obstructive sleep apnea, non-REM sleep parasomnias, nocturnal epileptic seizures, periodic limb movements, and psychiatric disorders. Treatment of RBD involves guidance on protecting the environment and avoiding injuries to the patient and bed partner/roommate. Use of medications are also reviewed in the article. The development of neuroprotective medications will be crucial for future RBD therapy.

1 October 2023 in Sleep Science
Verified
Journal Article
Open access
PDF file
LDLuciano Ferreira Drager
Luciano Ferreira Drager
MAMárcia Assis
Márcia Assis
ABAndrea Frota Rego Bacelar
Andrea Frota Rego Bacelar
DPDalva Lucia Rollemberg Poyares
Dalva Lucia Rollemberg Poyares
SCSilvia Gonçalves Conway
Silvia Gonçalves Conway
SMSandra Cristina Gonçalves Martinez
Sandra Cristina Gonçalves Martinez
Chronic insomnia disorder (simplified in this document as insomnia) is an increasingly common clinical condition in society and a frequent complaint at the offices of different areas of health practice (particularly Medicine and Psychology). This scenario has been accompanied by a significant evolution in treatment, as well as challenges in approaching patients in an appropriately way. This clinical guideline, coordinated by the Brazilian Sleep Association and the Brazilian Association of Sleep Medicine and counting on the active participation of various specialists in the area, encompasses an update on the diagnosis and treatment of insomnia in adults. To this end, it followed a structured methodology. Topics of interest related to diagnosis were written based on theoretical framework, evidence in the literature, and professional experience. As for the topics related to the treatment of insomnia, a series of questions were developed based on the PICO acronym (P – Patient, problem, or population; I – Intervention; C – Comparison, control, or comparator; O – Outcome). The work groups defined the eligible options within each of these parameters. Regarding pharmacological interventions, only the ones currently available in Brazil or possibly becoming available in the upcoming years were considered eligible. Systematic reviews were conducted to help prepare the texts and define the level of evidence for each intervention. The final result is an objective and practical document providing recommendations with the best scientific support available to professionals involved in the management of insomnia.

30 March 2023 in Sleep Medicine
Verified
Journal Article
Closed access
LCLarissa Tenório Andrade Correia
Larissa Tenório Andrade Correia
DCDaniel Gomes Coimbra
Daniel Gomes Coimbra
DGDaniel Leite Góes Gitaí
Daniel Leite Góes Gitaí
LGLívia Leite Góes Gitaí
Lívia Leite Góes Gitaí
TATiago Gomes de Andrade
Tiago Gomes de Andrade

19 August 2022 in The Cerebellum
Verified
Journal Article
Closed access
PDF file
LGLívia Leite Góes Gitaí
Lívia Leite Góes Gitaí
MSManoel Alves Sobreira-Neto
Manoel Alves Sobreira-Neto
PDPaula Rejane Beserra Diniz
Paula Rejane Beserra Diniz
AÉAlan Luiz Éckeli
Alan Luiz Éckeli
RFRegina Maria França Fernandes
Regina Maria França Fernandes
ASAntonio Carlos Santos
Antonio Carlos Santos

4 February 2024 in Chronobiology International
Verified
Journal Article
Closed access
PNPatrícia Pereira Nunes
Patrícia Pereira Nunes
CRCaroline Meneses Resende
Caroline Meneses Resende
ESEllen Dayanne Barros Silva
Ellen Dayanne Barros Silva
DBDeryc Cleyner Piones Bastos
Deryc Cleyner Piones Bastos
MFMax Luiz Mendes Ramires Filho
Max Luiz Mendes Ramires Filho
FTFlávio Teles
Flávio Teles
Changes in circadian rhythms have been observed in patients with chronic kidney disease (CKD), and evidence suggests that these changes can have a negative impact on health. This study aimed to investigate the existence of hemodialysis-induced chronodisruption, the chronotype distribution, and their association with sleep quality and quality of life (QoL). This was a cross-sectional study that enrolled 165 patients (mean age: 51.1 ± 12.5 y, 60.6% male) undergoing hemodialysis from three local units. The following instruments were used: the Morning-Eveningness Questionnaire (MEQ); a modified version of the Munich Chronotype Questionnaire (MCQT) to estimate hemodialysis-induced chronodisruption (HIC); the Kidney Disease QoL Short Form (KDQOL-SF); the Epworth Sleepiness Scale (ESS); the Pittsburgh Sleep Quality Index (PSQI) and the 10-Cognitive Screener (10-CS). HIC was present in 40.6% of CKD patients. Morning chronotype was prevalent in CKD patients (69%) compared to evening-type (17.1%) and significantly different from a paired sample from the general population (p < 0.001). HIC and chronotype were associated with different domains of QoL but not with sleep quality. This study suggests that there is a HIC and that morning chronotype is associated with CKD patients undergoing hemodialysis, with implications for QoL.

18 September 2020 in The Cerebellum
Verified
Journal Article
Closed access
PDF file
LGLívia Leite Góes Gitaí
Lívia Leite Góes Gitaí
AÉAlan Luiz Éckeli
Alan Luiz Éckeli
MSManoel Alves Sobreira-Neto
Manoel Alves Sobreira-Neto
PDPaula Rejane Beserra Diniz
Paula Rejane Beserra Diniz
ASAntônio Carlos Santos
Antônio Carlos Santos
RFRegina Maria França Fernandes
Regina Maria França Fernandes